nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—Voacamine—Vincristine—colon cancer	0.853	1	CrCrCtD
Rescinnamine—ACE—vein—colon cancer	0.0149	0.245	CbGeAlD
Rescinnamine—ACE—umbilical vein—colon cancer	0.0108	0.178	CbGeAlD
Rescinnamine—ACE—endothelium—colon cancer	0.00512	0.0845	CbGeAlD
Rescinnamine—ACE—blood vessel—colon cancer	0.00472	0.0779	CbGeAlD
Rescinnamine—Rosacea—Capecitabine—colon cancer	0.00345	0.0413	CcSEcCtD
Rescinnamine—ACE—embryo—colon cancer	0.00282	0.0465	CbGeAlD
Rescinnamine—SLC18A2—digestive system—colon cancer	0.00256	0.0422	CbGeAlD
Rescinnamine—Skin irritation—Fluorouracil—colon cancer	0.00249	0.0298	CcSEcCtD
Rescinnamine—ACE—epithelium—colon cancer	0.0023	0.0379	CbGeAlD
Rescinnamine—SLC18A2—vagina—colon cancer	0.00226	0.0373	CbGeAlD
Rescinnamine—Pigmentation disorder—Capecitabine—colon cancer	0.00226	0.027	CcSEcCtD
Rescinnamine—ACE—smooth muscle tissue—colon cancer	0.00222	0.0365	CbGeAlD
Rescinnamine—ACE—renal system—colon cancer	0.00213	0.0352	CbGeAlD
Rescinnamine—SLC18A2—liver—colon cancer	0.00191	0.0315	CbGeAlD
Rescinnamine—Voacamine—ABCB1—colon cancer	0.00187	0.647	CrCbGaD
Rescinnamine—Sunburn—Methotrexate—colon cancer	0.00186	0.0222	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Fluorouracil—colon cancer	0.00181	0.0217	CcSEcCtD
Rescinnamine—ACE—lymphoid tissue—colon cancer	0.00177	0.0292	CbGeAlD
Rescinnamine—Taste metallic—Methotrexate—colon cancer	0.00176	0.0211	CcSEcCtD
Rescinnamine—ACE—digestive system—colon cancer	0.00175	0.0288	CbGeAlD
Rescinnamine—ACE—bone marrow—colon cancer	0.00161	0.0266	CbGeAlD
Rescinnamine—SLC18A2—lymph node—colon cancer	0.00146	0.0241	CbGeAlD
Rescinnamine—Tingling sensation—Fluorouracil—colon cancer	0.00134	0.0161	CcSEcCtD
Rescinnamine—Stinging—Fluorouracil—colon cancer	0.00133	0.0159	CcSEcCtD
Rescinnamine—ACE—liver—colon cancer	0.0013	0.0215	CbGeAlD
Rescinnamine—Accidental injury—Irinotecan—colon cancer	0.00127	0.0152	CcSEcCtD
Rescinnamine—Skin hyperpigmentation—Capecitabine—colon cancer	0.00127	0.0152	CcSEcCtD
Rescinnamine—Eye irritation—Fluorouracil—colon cancer	0.00126	0.0151	CcSEcCtD
Rescinnamine—Cough increased—Irinotecan—colon cancer	0.00123	0.0147	CcSEcCtD
Rescinnamine—Lacrimation increased—Irinotecan—colon cancer	0.00122	0.0146	CcSEcCtD
Rescinnamine—Hypothyroidism—Capecitabine—colon cancer	0.00117	0.0141	CcSEcCtD
Rescinnamine—Lacrimation increased—Fluorouracil—colon cancer	0.00117	0.014	CcSEcCtD
Rescinnamine—Dermatitis contact—Fluorouracil—colon cancer	0.00107	0.0128	CcSEcCtD
Rescinnamine—Reserpine—ABCB1—colon cancer	0.00102	0.353	CrCbGaD
Rescinnamine—Herpes zoster—Capecitabine—colon cancer	0.001	0.012	CcSEcCtD
Rescinnamine—Osteoporosis—Methotrexate—colon cancer	0.001	0.012	CcSEcCtD
Rescinnamine—ACE—lymph node—colon cancer	0.000999	0.0165	CbGeAlD
Rescinnamine—Skin hyperpigmentation—Methotrexate—colon cancer	0.000943	0.0113	CcSEcCtD
Rescinnamine—Tingling sensation—Capecitabine—colon cancer	0.000937	0.0112	CcSEcCtD
Rescinnamine—Psoriasis—Methotrexate—colon cancer	0.000893	0.0107	CcSEcCtD
Rescinnamine—Injury—Irinotecan—colon cancer	0.000889	0.0106	CcSEcCtD
Rescinnamine—Eye irritation—Capecitabine—colon cancer	0.000883	0.0106	CcSEcCtD
Rescinnamine—Skin discolouration—Capecitabine—colon cancer	0.000834	0.00999	CcSEcCtD
Rescinnamine—Dermatitis bullous—Fluorouracil—colon cancer	0.000819	0.0098	CcSEcCtD
Rescinnamine—Lacrimation increased—Capecitabine—colon cancer	0.000818	0.00979	CcSEcCtD
Rescinnamine—Herpes zoster—Methotrexate—colon cancer	0.000745	0.00892	CcSEcCtD
Rescinnamine—Gingivitis—Methotrexate—colon cancer	0.000715	0.00856	CcSEcCtD
Rescinnamine—Abscess—Methotrexate—colon cancer	0.000709	0.00849	CcSEcCtD
Rescinnamine—Angina pectoris—Irinotecan—colon cancer	0.000688	0.00824	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Vincristine—colon cancer	0.000662	0.00793	CcSEcCtD
Rescinnamine—Angina pectoris—Fluorouracil—colon cancer	0.000659	0.00789	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Vincristine—colon cancer	0.000638	0.00763	CcSEcCtD
Rescinnamine—Myocardial infarction—Vincristine—colon cancer	0.000634	0.00759	CcSEcCtD
Rescinnamine—Skin discolouration—Methotrexate—colon cancer	0.000621	0.00743	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Irinotecan—colon cancer	0.000621	0.00743	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Fluorouracil—colon cancer	0.000618	0.00739	CcSEcCtD
Rescinnamine—Myocardial infarction—Irinotecan—colon cancer	0.000617	0.00739	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000595	0.00712	CcSEcCtD
Rescinnamine—Myocardial infarction—Fluorouracil—colon cancer	0.000591	0.00708	CcSEcCtD
Rescinnamine—Conjunctivitis—Fluorouracil—colon cancer	0.000586	0.00702	CcSEcCtD
Rescinnamine—Urinary tract infection—Fluorouracil—colon cancer	0.000586	0.00702	CcSEcCtD
Rescinnamine—Hypoaesthesia—Vincristine—colon cancer	0.000578	0.00692	CcSEcCtD
Rescinnamine—Dermatitis bullous—Capecitabine—colon cancer	0.000572	0.00685	CcSEcCtD
Rescinnamine—Rhinitis—Irinotecan—colon cancer	0.000567	0.00679	CcSEcCtD
Rescinnamine—Sinusitis—Fluorouracil—colon cancer	0.000566	0.00677	CcSEcCtD
Rescinnamine—Vaginal inflammation—Methotrexate—colon cancer	0.000561	0.00672	CcSEcCtD
Rescinnamine—Rhinitis—Fluorouracil—colon cancer	0.000543	0.0065	CcSEcCtD
Rescinnamine—Hypoaesthesia—Fluorouracil—colon cancer	0.000539	0.00645	CcSEcCtD
Rescinnamine—Pharyngitis—Fluorouracil—colon cancer	0.000537	0.00643	CcSEcCtD
Rescinnamine—Vaginal infection—Methotrexate—colon cancer	0.00053	0.00634	CcSEcCtD
Rescinnamine—Back pain—Vincristine—colon cancer	0.000489	0.00585	CcSEcCtD
Rescinnamine—Gastritis—Capecitabine—colon cancer	0.000484	0.0058	CcSEcCtD
Rescinnamine—Back pain—Irinotecan—colon cancer	0.000476	0.0057	CcSEcCtD
Rescinnamine—Influenza—Capecitabine—colon cancer	0.000473	0.00566	CcSEcCtD
Rescinnamine—Erythema—Fluorouracil—colon cancer	0.000471	0.00564	CcSEcCtD
Rescinnamine—Angina pectoris—Capecitabine—colon cancer	0.000461	0.00551	CcSEcCtD
Rescinnamine—Bronchitis—Capecitabine—colon cancer	0.000455	0.00544	CcSEcCtD
Rescinnamine—Hypertension—Vincristine—colon cancer	0.000436	0.00522	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Capecitabine—colon cancer	0.000432	0.00517	CcSEcCtD
Rescinnamine—Myalgia—Vincristine—colon cancer	0.00043	0.00515	CcSEcCtD
Rescinnamine—Cough—Irinotecan—colon cancer	0.00043	0.00514	CcSEcCtD
Rescinnamine—Hypertension—Irinotecan—colon cancer	0.000425	0.00509	CcSEcCtD
Rescinnamine—Acute coronary syndrome—Capecitabine—colon cancer	0.000416	0.00497	CcSEcCtD
Rescinnamine—Discomfort—Irinotecan—colon cancer	0.000414	0.00496	CcSEcCtD
Rescinnamine—Myocardial infarction—Capecitabine—colon cancer	0.000413	0.00495	CcSEcCtD
Rescinnamine—Oedema—Vincristine—colon cancer	0.000412	0.00494	CcSEcCtD
Rescinnamine—Infection—Vincristine—colon cancer	0.00041	0.00491	CcSEcCtD
Rescinnamine—Urinary tract infection—Capecitabine—colon cancer	0.00041	0.00491	CcSEcCtD
Rescinnamine—Conjunctivitis—Capecitabine—colon cancer	0.00041	0.00491	CcSEcCtD
Rescinnamine—Oedema—Irinotecan—colon cancer	0.000402	0.00481	CcSEcCtD
Rescinnamine—Myalgia—Fluorouracil—colon cancer	0.000401	0.0048	CcSEcCtD
Rescinnamine—Infection—Irinotecan—colon cancer	0.000399	0.00478	CcSEcCtD
Rescinnamine—Discomfort—Fluorouracil—colon cancer	0.000397	0.00475	CcSEcCtD
Rescinnamine—Oedema—Fluorouracil—colon cancer	0.000385	0.00461	CcSEcCtD
Rescinnamine—Infection—Fluorouracil—colon cancer	0.000382	0.00458	CcSEcCtD
Rescinnamine—Rhinitis—Capecitabine—colon cancer	0.000379	0.00454	CcSEcCtD
Rescinnamine—Hypoaesthesia—Capecitabine—colon cancer	0.000377	0.00451	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000376	0.0045	CcSEcCtD
Rescinnamine—Pharyngitis—Capecitabine—colon cancer	0.000376	0.0045	CcSEcCtD
Rescinnamine—Insomnia—Vincristine—colon cancer	0.000373	0.00447	CcSEcCtD
Rescinnamine—Paraesthesia—Vincristine—colon cancer	0.00037	0.00443	CcSEcCtD
Rescinnamine—Insomnia—Irinotecan—colon cancer	0.000363	0.00435	CcSEcCtD
Rescinnamine—Paraesthesia—Irinotecan—colon cancer	0.000361	0.00432	CcSEcCtD
Rescinnamine—Constipation—Vincristine—colon cancer	0.000353	0.00422	CcSEcCtD
Rescinnamine—Pain—Vincristine—colon cancer	0.000353	0.00422	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000351	0.0042	CcSEcCtD
Rescinnamine—Insomnia—Fluorouracil—colon cancer	0.000348	0.00417	CcSEcCtD
Rescinnamine—Paraesthesia—Fluorouracil—colon cancer	0.000345	0.00414	CcSEcCtD
Rescinnamine—Constipation—Irinotecan—colon cancer	0.000344	0.00411	CcSEcCtD
Rescinnamine—Pain—Irinotecan—colon cancer	0.000344	0.00411	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Vincristine—colon cancer	0.000337	0.00404	CcSEcCtD
Rescinnamine—Erythema—Capecitabine—colon cancer	0.000329	0.00394	CcSEcCtD
Rescinnamine—Pain—Fluorouracil—colon cancer	0.000329	0.00394	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Irinotecan—colon cancer	0.000328	0.00393	CcSEcCtD
Rescinnamine—Abdominal pain—Vincristine—colon cancer	0.000326	0.0039	CcSEcCtD
Rescinnamine—Dysgeusia—Capecitabine—colon cancer	0.000323	0.00386	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Methotrexate—colon cancer	0.000321	0.00385	CcSEcCtD
Rescinnamine—Back pain—Capecitabine—colon cancer	0.000319	0.00381	CcSEcCtD
Rescinnamine—Abdominal pain—Irinotecan—colon cancer	0.000318	0.0038	CcSEcCtD
Rescinnamine—Urticaria—Fluorouracil—colon cancer	0.000306	0.00366	CcSEcCtD
Rescinnamine—Conjunctivitis—Methotrexate—colon cancer	0.000305	0.00365	CcSEcCtD
Rescinnamine—Hypersensitivity—Vincristine—colon cancer	0.000304	0.00364	CcSEcCtD
Rescinnamine—Hypersensitivity—Irinotecan—colon cancer	0.000296	0.00354	CcSEcCtD
Rescinnamine—Cough—Capecitabine—colon cancer	0.000287	0.00344	CcSEcCtD
Rescinnamine—Hypertension—Capecitabine—colon cancer	0.000284	0.0034	CcSEcCtD
Rescinnamine—Hypersensitivity—Fluorouracil—colon cancer	0.000283	0.00339	CcSEcCtD
Rescinnamine—Myalgia—Capecitabine—colon cancer	0.00028	0.00336	CcSEcCtD
Rescinnamine—Pharyngitis—Methotrexate—colon cancer	0.00028	0.00335	CcSEcCtD
Rescinnamine—Discomfort—Capecitabine—colon cancer	0.000277	0.00332	CcSEcCtD
Rescinnamine—Dizziness—Vincristine—colon cancer	0.000273	0.00327	CcSEcCtD
Rescinnamine—Pruritus—Fluorouracil—colon cancer	0.000272	0.00326	CcSEcCtD
Rescinnamine—Oedema—Capecitabine—colon cancer	0.000269	0.00322	CcSEcCtD
Rescinnamine—Infection—Capecitabine—colon cancer	0.000267	0.0032	CcSEcCtD
Rescinnamine—Dizziness—Irinotecan—colon cancer	0.000266	0.00318	CcSEcCtD
Rescinnamine—Rash—Vincristine—colon cancer	0.00026	0.00311	CcSEcCtD
Rescinnamine—Dermatitis—Vincristine—colon cancer	0.00026	0.00311	CcSEcCtD
Rescinnamine—Headache—Vincristine—colon cancer	0.000258	0.00309	CcSEcCtD
Rescinnamine—Dizziness—Fluorouracil—colon cancer	0.000254	0.00305	CcSEcCtD
Rescinnamine—Rash—Irinotecan—colon cancer	0.000253	0.00303	CcSEcCtD
Rescinnamine—Dermatitis—Irinotecan—colon cancer	0.000253	0.00303	CcSEcCtD
Rescinnamine—Headache—Irinotecan—colon cancer	0.000252	0.00301	CcSEcCtD
Rescinnamine—Erythema—Methotrexate—colon cancer	0.000245	0.00294	CcSEcCtD
Rescinnamine—Nausea—Vincristine—colon cancer	0.000245	0.00293	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000245	0.00293	CcSEcCtD
Rescinnamine—Insomnia—Capecitabine—colon cancer	0.000243	0.00291	CcSEcCtD
Rescinnamine—Rash—Fluorouracil—colon cancer	0.000243	0.0029	CcSEcCtD
Rescinnamine—Dermatitis—Fluorouracil—colon cancer	0.000242	0.0029	CcSEcCtD
Rescinnamine—Paraesthesia—Capecitabine—colon cancer	0.000241	0.00289	CcSEcCtD
Rescinnamine—Headache—Fluorouracil—colon cancer	0.000241	0.00289	CcSEcCtD
Rescinnamine—Dysgeusia—Methotrexate—colon cancer	0.00024	0.00287	CcSEcCtD
Rescinnamine—Nausea—Irinotecan—colon cancer	0.000239	0.00286	CcSEcCtD
Rescinnamine—Back pain—Methotrexate—colon cancer	0.000237	0.00284	CcSEcCtD
Rescinnamine—Pain—Capecitabine—colon cancer	0.00023	0.00275	CcSEcCtD
Rescinnamine—Constipation—Capecitabine—colon cancer	0.00023	0.00275	CcSEcCtD
Rescinnamine—Nausea—Fluorouracil—colon cancer	0.000229	0.00274	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Capecitabine—colon cancer	0.00022	0.00263	CcSEcCtD
Rescinnamine—Cough—Methotrexate—colon cancer	0.000214	0.00256	CcSEcCtD
Rescinnamine—Urticaria—Capecitabine—colon cancer	0.000214	0.00256	CcSEcCtD
Rescinnamine—Abdominal pain—Capecitabine—colon cancer	0.000213	0.00254	CcSEcCtD
Rescinnamine—Myalgia—Methotrexate—colon cancer	0.000209	0.0025	CcSEcCtD
Rescinnamine—Discomfort—Methotrexate—colon cancer	0.000206	0.00247	CcSEcCtD
Rescinnamine—Infection—Methotrexate—colon cancer	0.000199	0.00238	CcSEcCtD
Rescinnamine—Hypersensitivity—Capecitabine—colon cancer	0.000198	0.00237	CcSEcCtD
Rescinnamine—Pruritus—Capecitabine—colon cancer	0.00019	0.00228	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000182	0.00218	CcSEcCtD
Rescinnamine—Insomnia—Methotrexate—colon cancer	0.000181	0.00217	CcSEcCtD
Rescinnamine—Paraesthesia—Methotrexate—colon cancer	0.00018	0.00215	CcSEcCtD
Rescinnamine—Dizziness—Capecitabine—colon cancer	0.000178	0.00213	CcSEcCtD
Rescinnamine—Pain—Methotrexate—colon cancer	0.000171	0.00205	CcSEcCtD
Rescinnamine—Rash—Capecitabine—colon cancer	0.00017	0.00203	CcSEcCtD
Rescinnamine—Dermatitis—Capecitabine—colon cancer	0.000169	0.00203	CcSEcCtD
Rescinnamine—Headache—Capecitabine—colon cancer	0.000168	0.00202	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Methotrexate—colon cancer	0.000164	0.00196	CcSEcCtD
Rescinnamine—Nausea—Capecitabine—colon cancer	0.00016	0.00191	CcSEcCtD
Rescinnamine—Urticaria—Methotrexate—colon cancer	0.000159	0.0019	CcSEcCtD
Rescinnamine—Abdominal pain—Methotrexate—colon cancer	0.000158	0.00189	CcSEcCtD
Rescinnamine—Hypersensitivity—Methotrexate—colon cancer	0.000147	0.00177	CcSEcCtD
Rescinnamine—Pruritus—Methotrexate—colon cancer	0.000142	0.0017	CcSEcCtD
Rescinnamine—Dizziness—Methotrexate—colon cancer	0.000132	0.00158	CcSEcCtD
Rescinnamine—Rash—Methotrexate—colon cancer	0.000126	0.00151	CcSEcCtD
Rescinnamine—Dermatitis—Methotrexate—colon cancer	0.000126	0.00151	CcSEcCtD
Rescinnamine—Headache—Methotrexate—colon cancer	0.000125	0.0015	CcSEcCtD
Rescinnamine—Nausea—Methotrexate—colon cancer	0.000119	0.00142	CcSEcCtD
